Injectable Drug Delivery News

  1. INCOG BioPharma Completes Construction Of Cleanrooms, On Track To Manufacture Injectable Drug Products In Q3 2022 4/5/2022

    INCOG BioPharma Services, an Indiana-based contract development and manufacturing organization (CDMO) reached another major milestone in its facility by completing the construction of its cleanroom production area within the new 90,000 sq. ft. bio/pharmaceutical manufacturing site.

  2. Viatris Inc. Announces Receipt Of The First FDA Approval For Generic Version Of Symbicort® Inhalation Aerosol, Breyna™ (Budesonide And Formoterol Fumarate Dihydrate Inhalation Aerosol), In Partnership With Kindeva 3/16/2022

    Viatris Inc. and Kindeva Drug Delivery announced that, Mylan Pharmaceuticals Inc., a Viatris subsidiary, has received approval from the U.S. FDA for its Abbreviated New Drug Application (ANDA) for BreynaTM (Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol), the first approved generic version of AstraZeneca’s Symbicort®.

  3. Sanofi Announces €300 Million Collaboration With Blackstone Life Sciences To Advance An Innovative Treatment For Multiple Myeloma 3/15/2022

    Sanofi and Blackstone (NYSE: BX) today announced a strategic, risk-sharing collaboration under which funds managed by Blackstone Life Sciences (BXLS) will contribute up to €300 million to accelerate the global pivotal studies and the clinical development program for the subcutaneous formulation and delivery of the anti-CD38 antibody Sarclisa®, to treat patients with multiple myeloma (MM).

  4. INCOG BioPharma Services Completes Analytical And Quality Control Testing Laboratory & Technology Transfer Suite 3/1/2022

    The newly designed analytical chemistry and microbiology laboratories will provide a wide range of essential biological and chemical testing capabilities to support sterile injectable drug product fulfillment programs, including sterility testing.

  5. Alcami Adds Additional Formulation Development Capabilities 3/1/2022

    Alcami, a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), announced today the addition of a 3,800 ft² Non-GMP Formulation Development Laboratory (FDL). The dedicated Non-GMP formulation development space, which is co-located within the same facility as Alcami's parenteral manufacturing operation that offers four isolator filling lines for liquid and lyophilized products, is ready to support customers with Preclinical and Clinical development programs.

  6. CDMO Recro Adds New Filling And Lyophilization Equipment To Meet Industry's Needs 2/24/2022

    Recro Pharma, Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today reported key progress in adding fill/finish and lyophilization capabilities to its broad suite of CDMO offerings. All construction and equipment installation related to this service expansion has been completed at the company’s San Diego facility and final validation and commissioning activities are underway.

  7. Kindeva Drug Delivery To Manufacture New, Greener Inhalers At UK Manufacturing Site To Help Cut Carbon Emissions 2/16/2022

    One of the UK’s biggest asthma inhaler manufacturers has today announced its intention to invest in its UK manufacturing site to support the development of a new generation of greener inhalers, designed to help support the National Health Service (NHS) to cut a contributor to its emissions.

  8. CDMO PCI Pharma Services Adds 3 Vanrx Sterile Filling Systems To Meet Industry Needs 2/3/2022

    PCI Pharma Services is pleased to announce the addition of three new exceptional automated sterile fill-finish machines in our San Diego and Melbourne facilities. Purchased from Cytiva, this remarkable equipment can pivot between filling different sterile medications into vials and syringes. The addition of these machines comes after our recent acquisition of Lyophilization Services of New England, Inc. (LSNE), specialists in the manufacturing of complex injectables for biologics and small molecules, bringing even broader capabilities to PCI clients across the entire product lifecycle and allowing them to bring their life-changing therapies to market with increased speed and safety.

  9. Global Pharmaceutical Packaging Manufacturer To Invest More Than $70 Million In Kinston Expansion 2/1/2022

    West Pharmaceutical Services, Inc. [NYSE: WST], a global leader in innovative solutions for injectable drug administration, will create approximately 70 jobs in Lenoir County, Governor Roy Cooper announced.

  10. West Announces Landmark Collaboration With Corning In Pharmaceutical Injectable Drug Delivery 1/26/2022

    The exclusive long-term supply and development agreement includes a multimillion-dollar capital and R&D investment in Corning to enable advanced drug containment and delivery system solutions.